Open access
6,873
Views
149
CrossRef citations to date
0
Altmetric
Report
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
Daniel Ayoub Centre d'Immunologie Pierre Fabre; St Julien-en-Genevois, FranceCorrespondence[email protected] [email protected] [email protected]
, Wolfgang Jabs Bruker Daltonik GmbH; Bremen, GermanyCorrespondence[email protected] [email protected] [email protected]
, Anja Resemann Bruker Daltonik GmbH; Bremen, Germany
, Waltraud Evers Bruker Daltonik GmbH; Bremen, Germany
, Catherine Evans Bruker Daltonics GmbH;Fällanden, Switzerland
, Laura Main Bruker Daltonics Ltd.; Coventry, UK
, Carsten Baessmann Bruker Daltonik GmbH; Bremen, Germany
, Elsa Wagner-Rousset Centre d'Immunologie Pierre Fabre; St Julien-en-Genevois, France
, Detlev Suckau Bruker Daltonik GmbH; Bremen, Germany
& Alain Beck Centre d'Immunologie Pierre Fabre; St Julien-en-Genevois, FranceCorrespondence[email protected] [email protected] [email protected]
show all
Pages 699-710
|
Received 08 May 2013, Accepted 15 Jun 2013, Published online: 20 Jun 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.